{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:08:45Z","timestamp":1788570525245,"version":"build-2803163510"},"reference-count":21,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014089","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["4111206"],"award-info":[{"award-number":["4111206"]}],"id":[{"id":"10.13039\/501100014089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014089","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["CS 40009\u201354220"],"award-info":[{"award-number":["CS 40009\u201354220"]}],"id":[{"id":"10.13039\/501100014089","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ANSES-Nancy","award":["4111206"],"award-info":[{"award-number":["4111206"]}]},{"name":"ANSES-Nancy","award":["CS 40009\u201354220"],"award-info":[{"award-number":["CS 40009\u201354220"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Seven brands of veterinary rabies vaccines are commercially available in Sri Lanka, but there is no established procedure to test the potency of the vaccines at the local level, especially prior to their release. The aim of this study was to test the potency of these vaccines using a mouse challenge test in collaboration with the EU\/WOAH\/WHO Reference Laboratory for Rabies, ANSES-Nancy, France. Based on the European Pharmacopoeia, the inactivated rabies vaccines complied with the mouse potency test if the estimated potency is \u22651.0 IU in the smallest prescribed dose. Among the eight tested vaccines, four single-dose preparations (Rabisin\u2122, Raksharab\u2122, Nobivac\u2122 RL, and Nobivac\u2122 Rabies) were compliant, with potencies of 12 IU\/dose, 7.2 IU\/dose, 4.4 IU\/dose, and 3.4 IU\/dose, respectively. Three of the single-dose preparations (Canvac\u2122 R, Defensor\u2122 3, and Rabies killed vaccine) were not compliant, with potency values &lt;1.0 IU\/dose. One multidose preparation (Raksharab\u2122 multidose) had a potency of 1.3 IU\/dose, even though the test was not validated. Based on these results, it appears that some rabies vaccine batches that are currently available in the local market do not comply with the mouse potency test. Testing the vaccines\u2019 potency before registration and release to the market appears to be an important step to allow good immunization to animals during pre-exposure vaccination programs.<\/jats:p>","DOI":"10.3390\/vaccines11050961","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T03:49:06Z","timestamp":1683690546000},"page":"961","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Potency of Veterinary Rabies Vaccines Marketed in Sri Lanka"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4371-3230","authenticated-orcid":false,"given":"Hasanthi","family":"Rathnadiwakara","sequence":"first","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Colombo, Colombo 00800, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangala","family":"Gunatilake","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Colombo, Colombo 00800, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4753-6614","authenticated-orcid":false,"given":"Alexandre","family":"Servat","sequence":"additional","affiliation":[{"name":"EU\/WOAH\/WHO Reference Laboratory for Rabies, OMCL for Rabies Vaccines, 54220 Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5054-3634","authenticated-orcid":false,"given":"Marine","family":"Wasniewski","sequence":"additional","affiliation":[{"name":"EU\/WOAH\/WHO Reference Laboratory for Rabies, OMCL for Rabies Vaccines, 54220 Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Thibault","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim, 69007 Lyon, France"},{"name":"JC & P Life Science Partner, 04300 Forcalquier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Cliquet","sequence":"additional","affiliation":[{"name":"EU\/WOAH\/WHO Reference Laboratory for Rabies, OMCL for Rabies Vaccines, 54220 Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17091","DOI":"10.1038\/nrdp.2017.91","article-title":"Rabies","volume":"3","author":"Fooks","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.vaccine.2019.03.037","article-title":"Avoiding preventable deaths: The scourge of counterfeit rabies vaccines","volume":"37","author":"Taylor","year":"2019","journal-title":"Vaccine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1017\/S0950268807000131","article-title":"Inferior rabies vaccine quality and low immunization coverage in dogs (Canis familiaris) in China","volume":"136","author":"Hu","year":"2008","journal-title":"Epidemiol. Infect."},{"key":"ref_4","unstructured":"Sri Lanka Death Statistics (2023, February 27). Public Health Veterinary Services, Available online: http:\/\/www.rabies.gov.lk\/english\/static.php."},{"key":"ref_5","unstructured":"Weekly Epidemiological Report (2021, July 13). Human Rabies, Available online: https:\/\/www.epid.gov.lk\/web\/images\/pdf\/wer\/2017\/vol_44_no_09-english.pdf."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/014107680209500104","article-title":"Rabies in North America and Europe","volume":"95","author":"Finnegan","year":"2002","journal-title":"J. R. Soc. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vetmic.2006.04.009","article-title":"Canine vaccination--providing broader benefits for disease control","volume":"117","author":"Cleaveland","year":"2006","journal-title":"Vet. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S1473-3099(15)00402-8","article-title":"Mission Indradhanush and the counterfeit drug trade in India","volume":"15","author":"Banerjee","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/026119291504300106","article-title":"A step forward in the quality control testing of inactivated rabies vaccines\u2014Extensive evaluation of European vaccines by using alternative methods to the in vivo potency tests","volume":"43","author":"Servat","year":"2015","journal-title":"Altern. Lab. Anim."},{"key":"ref_10","first-page":"57","article-title":"EDQM biological reference preparation for rabies vaccine (inactivated) for veterinary use","volume":"2015","author":"Daas","year":"2015","journal-title":"Pharmeuropa Bio Sci. Notes"},{"key":"ref_11","unstructured":"Anon (2013). European Pharmacopoeia, Council of Europe. [8th ed.]."},{"key":"ref_12","first-page":"180","article-title":"The NIH test for potency testing of rabies vaccines","volume":"Volume 2","author":"Rupprecht","year":"2018","journal-title":"Current Laboratory Techniques in Rabies Diagnosis, Research and Prevention"},{"key":"ref_13","first-page":"655","article-title":"In vivo potency tests of rabies inactivated vaccines for veterinary use. A 2-year retrospective analysis of data according to the criteria of the European Pharmacopoeia","volume":"20","author":"Servat","year":"2008","journal-title":"Pharmeuropa Bio Sci. Notes"},{"key":"ref_14","unstructured":"(2022, August 29). World Health Organization (WHO), Food and Agriculture Organization of the United Nations (FAO), and World Organization for Animal Health (WOAH) (2019) United Against Rabie Collaboration. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/328053\/WHO-CDS-NTD-NZD-2019.04-eng.pdf?sequence=1&isAllowed=y."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ertl, H.C.J. (2020). Rabies and Rabies Vaccines, Springer.","DOI":"10.1007\/978-3-030-21084-7"},{"key":"ref_16","unstructured":"Rupprecht, C.E., Fooks, A.R., and Abela-Ridder, B. (2022, August 29). Laboratory Techniques in Rabies, Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/310836."},{"key":"ref_17","first-page":"279","article-title":"Laboratory techniques in rabies: The NIH test for potency","volume":"23","author":"Seligmann","year":"1973","journal-title":"Monogr. Ser. World Health Organ."},{"key":"ref_18","first-page":"37","article-title":"Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use","volume":"2","author":"Bruckner","year":"2010","journal-title":"Pharmeuropa Bio Sci. Notes"},{"key":"ref_19","unstructured":"Russell, W.M.S., and Burch, R.L. (1959). The Principles of Humane Experimental Technique, Methuen."},{"key":"ref_20","first-page":"216","article-title":"The health and economic effects of counterfeit drugs","volume":"7","author":"Blackstone","year":"2014","journal-title":"Am. Health Drug Benefits"},{"key":"ref_21","unstructured":"(2023, February 28). Development of Sri Lanka\u2019s National Strategic Plan for the Elimination of Dog-Mediated Human Rabies (2022\u20132026), World Health Organization, South-East Asia News. Available online: https:\/\/www.who.int\/southeastasia\/news\/feature-stories\/detail\/development-of-sri-lanka-s-national-strategic-plan-for-the-elimination-of-dog-mediated-human-rabies-(2022-2026)."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/5\/961\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:32:05Z","timestamp":1760124725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/5\/961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["vaccines11050961"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11050961","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]}}}